SkinBioTherapeutics (UK) Price on November 26, 2024
| SBTX Stock | 16.00 0.12 0.76% |
Below is the normalized historical share price chart for SkinBioTherapeutics PLC extending back to April 05, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of SkinBioTherapeutics stands at 16.00, as last reported on the 2nd of December, with the highest price reaching 16.25 and the lowest price hitting 15.82 during the day.
If you're considering investing in SkinBioTherapeutics Stock, it is important to understand the factors that can impact its price. SkinBioTherapeutics appears to be somewhat reliable, given 3 months investment horizon. SkinBioTherapeutics PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0955, which indicates the firm had a 0.0955% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for SkinBioTherapeutics PLC, which you can use to evaluate the volatility of the company. Please review SkinBioTherapeutics' Coefficient Of Variation of 954.09, risk adjusted performance of 0.0884, and Semi Deviation of 3.15 to confirm if our risk estimates are consistent with your expectations.
At this time, SkinBioTherapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 3.6 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 1.1 M in 2024. . SkinBioTherapeutics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 11.1941 | 50 Day MA 13.9225 | Beta 1.753 |
SkinBioTherapeutics |
Sharpe Ratio = 0.0955
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SBTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.53 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average SkinBioTherapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SkinBioTherapeutics by adding it to a well-diversified portfolio.
Price Book 10.0107 | Enterprise Value Ebitda (8.08) | Price Sales 226.1071 | Shares Float 143.4 M | Wall Street Target Price 56 |
SkinBioTherapeutics Valuation on November 26, 2024
It is possible to determine the worth of SkinBioTherapeutics on a given historical date. On November 26, 2024 SkinBioTherapeutics was worth 15.88 at the beginning of the trading date compared to the closed value of 15.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of SkinBioTherapeutics stock. Still, in general, we apply an absolute valuation method to find SkinBioTherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of SkinBioTherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against SkinBioTherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 16.00 | 16.29 | 15.75 | 15.88 | 894,038 | |
11/26/2024 | 15.88 | 16.07 | 15.86 | 15.88 | 165,889 |
| 15.88 | 16.25 | 15.75 | 15.88 | 867,814 |
| Backtest SkinBioTherapeutics | | | SkinBioTherapeutics History | | | SkinBioTherapeutics Valuation | Previous | Next |
SkinBioTherapeutics Trading Date Momentum on November 26, 2024
| On November 27 2024 SkinBioTherapeutics PLC was traded for 15.88 at the closing time. The highest price during the trading period was 16.25 and the lowest recorded bid was listed for 15.75 . The volume for the day was 867.8 K. This history from November 27, 2024 did not result in any price rise and fall. The trading price change to the current price is 0.76% . |
SkinBioTherapeutics PLC Fundamentals Correlations and Trends
By evaluating SkinBioTherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among SkinBioTherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. SkinBioTherapeutics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About SkinBioTherapeutics Stock history
SkinBioTherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for SkinBioTherapeutics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in SkinBioTherapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing SkinBioTherapeutics stock prices may prove useful in developing a viable investing in SkinBioTherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 189.4 M | 139.6 M | |
| Net Loss | -2.3 M | -2.2 M |
SkinBioTherapeutics Quarterly Net Working Capital |
|
SkinBioTherapeutics Stock Technical Analysis
SkinBioTherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
SkinBioTherapeutics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
SkinBioTherapeutics PLC cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
SkinBioTherapeutics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how SkinBioTherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SkinBioTherapeutics shares will generate the highest return on investment. By undertsting and applying SkinBioTherapeutics stock market strength indicators, traders can identify SkinBioTherapeutics PLC entry and exit signals to maximize returns
SkinBioTherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for SkinBioTherapeutics' price direction in advance. Along with the technical and fundamental analysis of SkinBioTherapeutics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of SkinBioTherapeutics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0884 | |||
| Jensen Alpha | 0.5814 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | 0.076 | |||
| Treynor Ratio | (0.50) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for SkinBioTherapeutics Stock Analysis
When running SkinBioTherapeutics' price analysis, check to measure SkinBioTherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SkinBioTherapeutics is operating at the current time. Most of SkinBioTherapeutics' value examination focuses on studying past and present price action to predict the probability of SkinBioTherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SkinBioTherapeutics' price. Additionally, you may evaluate how the addition of SkinBioTherapeutics to your portfolios can decrease your overall portfolio volatility.